# To Evaluate SBI in the Dietary Management of Mild to Moderate Crohn's Disease

> **NCT02649075** · NA · TERMINATED · sponsor: **Entera Health, Inc** · enrollment: 7 (actual)

## Conditions studied

- Crohn's Disease

## Interventions

- **OTHER:** Serum-derived Bovine Immunoglobulin / Protein Isolate
- **OTHER:** Placebo

## Key facts

- **NCT ID:** NCT02649075
- **Lead sponsor:** Entera Health, Inc
- **Sponsor class:** INDUSTRY
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2016-02
- **Primary completion:** 2017-08
- **Final completion:** 2017-08
- **Target enrollment:** 7 (ACTUAL)
- **Why stopped:** Lack of enrollment.
- **Last updated:** 2017-10-04


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02649075

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02649075, "To Evaluate SBI in the Dietary Management of Mild to Moderate Crohn's Disease". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT02649075. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*